Blog

A Primer to Using Whole Genome Sequencing for Infection Prevention
Insights

A Primer to Using Whole Genome Sequencing for Infection Prevention

Whole genome sequencing (WGS) is a powerful tool for understanding and preventing infections. By reading the complete DNA sequence of an organism, WGS can help identify and track the spread of pathogens. This guide will explain how WGS works, its applications in healthcare, and its potential to improve infection control.
Kerkko Visuri
Upgraded candida.app empowers global surveillance of deadly fungus Candida auris
Company News

Upgraded candida.app empowers global surveillance of deadly fungus Candida auris

We’re excited to announce a major update to candida.app, allowing users to rapidly compare their Candida auris isolates to public genomic surveillance data
Kerkko Visuri
What is Genomic Surveillance?
Insights

What is Genomic Surveillance?

Discover what genomic surveillance is, its benefits, methods, and applications in healthcare, public health, and food safety. Understand the factors to consider when starting genomic surveillance in your organization, its challenges, and how to choose the right sequencing methods.
Kerkko Visuri
Solu Launches the Fastest Accessible Online Tool for Analyzing and Preventing Candida Auris Outbreaks with Genomes
Company News

Solu Launches the Fastest Accessible Online Tool for Analyzing and Preventing Candida Auris Outbreaks with Genomes

Solu’s Candida.app tool enables quick and easy genomic characterization of Candida auris, improving the classification and management of new outbreaks, and helping epidemiologists prevent further outbreaks.
Sam Sihvonen
What is Solu?
Company News

What is Solu?

The first real-time database of bacteria and their evolution.
Sam Sihvonen
Sequencing technology is ready for a breakthrough, but the UX is broken – why the golden age of genomics is about to start
Insights

Sequencing technology is ready for a breakthrough, but the UX is broken – why the golden age of genomics is about to start

Our co-founder Timo explains why now is the perfect timing for a genomics company.
Timo Moilanen